Page last updated: 2024-11-09

cystine dimethyl ester

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cystine dimethyl ester: RN given refers to (L)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID2724377
CHEMBL ID4228994
SCHEMBL ID111173
MeSH IDM0106524

Synonyms (18)

Synonym
unii-veo23d129r
dimethyl-l-cystine
cdme
cystine dimethyl ester
veo23d129r ,
1069-29-0
l-cystine, dimethyl ester
dimethyl cystinate
cystine, dimethyl ester
methyl (2r)-2-amino-3-[[(2r)-2-amino-3-methoxy-3-oxopropyl]disulfanyl]propanoate
SCHEMBL111173
l-cystine, 1,1'-dimethyl ester
dimethyl cystinate [inci]
dimethyl l-cystinate
NXPNPYNCKSWEHA-WDSKDSINSA-N
Q27291789
CHEMBL4228994
PD196659

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1627235Inhibition of hexagonal L-cystine plate crystal growth assessed as step velocity for crystal growth rate at 15 uM after 25 mins by atomic force microscopic analysis relative to control2016Journal of medicinal chemistry, Aug-11, Volume: 59, Issue:15
l-Cystine Diamides as l-Cystine Crystallization Inhibitors for Cystinuria.
AID1627236Half life in pH 7.4 phosphate buffered saline at 100 uM at 37 degC by LC-MS/MS analysis2016Journal of medicinal chemistry, Aug-11, Volume: 59, Issue:15
l-Cystine Diamides as l-Cystine Crystallization Inhibitors for Cystinuria.
AID1627241Inhibition of hexagonal L-cystine plate crystal growth assessed as reduction in crystal mass yield at 15 to 45 uM after 25 mins by atomic force microscopic analysis2016Journal of medicinal chemistry, Aug-11, Volume: 59, Issue:15
l-Cystine Diamides as l-Cystine Crystallization Inhibitors for Cystinuria.
AID1391210Inhibition of L-cystine crystallization assessed as increase in apparent aqueous solubility after 72 hrs by fluorescence assay2018Bioorganic & medicinal chemistry letters, 05-01, Volume: 28, Issue:8
Design, synthesis, and evaluation of l-cystine diamides as l-cystine crystallization inhibitors for cystinuria.
AID1627238Inhibition of L-cystine crystallization assessed as concentration required to double metastable supersaturation range of L-cystine after 72 hrs by OPA/NBC derivatization based fluorescence assay2016Journal of medicinal chemistry, Aug-11, Volume: 59, Issue:15
l-Cystine Diamides as l-Cystine Crystallization Inhibitors for Cystinuria.
AID1627234Inhibition of hexagonal L-cystine plate crystal growth assessed as step velocity for crystal growth rate at 30 uM after 25 mins by atomic force microscopic analysis relative to control2016Journal of medicinal chemistry, Aug-11, Volume: 59, Issue:15
l-Cystine Diamides as l-Cystine Crystallization Inhibitors for Cystinuria.
AID1627242Inhibition of hexagonal L-cystine plate crystal growth assessed as induction of plate to rod crystal morphology at 15 to 45 uM after 25 mins by atomic force microscopic analysis2016Journal of medicinal chemistry, Aug-11, Volume: 59, Issue:15
l-Cystine Diamides as l-Cystine Crystallization Inhibitors for Cystinuria.
AID1627233Inhibition of hexagonal L-cystine plate crystal growth assessed as step velocity for crystal growth rate at 45 uM after 25 mins by atomic force microscopic analysis relative to control2016Journal of medicinal chemistry, Aug-11, Volume: 59, Issue:15
l-Cystine Diamides as l-Cystine Crystallization Inhibitors for Cystinuria.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (24.24)18.7374
1990's10 (30.30)18.2507
2000's7 (21.21)29.6817
2010's5 (15.15)24.3611
2020's3 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.02

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.02 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.02)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.94%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other33 (97.06%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]